Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Mutation Research|November 1, 1987
Exogenous O6-methylguanine inhibits adduct removal and sensitizes human cells to killing by the chemical carcinogen N-methyl-N'-nitro-N-nitrosoguanidineM A Babich, R S Day
Clinical Science and Molecular Medicine|January 1, 1976
Absence of an acute effect of calcium or parathyroid hormone administration on plasma renin activity in manS Epstein, J Sagel, H Brodovcky, et al.
Oncogenesis|January 26, 2016
Hypoxia and metabolic adaptation of cancer cellsK L Eales, K E R Hollinshead, D A Tennant
The American Journal of Medicine|June 1, 1982
Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchangeP Disler, R Day, N Burman, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|March 3, 2004
Modeling cellular processes with variational Bayesian cooperative vector quantizerX Lu, M Hauskrecht, R S Day
International Journal of Surgery (London, England)|April 28, 2007
The systemic inflammatory response syndrome and cardiopulmonary bypassJ R S Day, K M Taylor
Mutation Research|June 1, 1978
Excision repair by human fibroblasts of DNA damaged by r-7, t-8-dihyroxy-t-9,10-oxy-7,8,9,10- tetrahydrobenzo(a)pyreneR S Day, D Scudiero, M Dimattina
Annals of Clinical Research|January 1, 1976
Hepatic haem metabolism in porphyria cutanea tarda (PCT): enzymatic studies and their relation to liver ultrastructureG H Blekkenhorst, N R Pimstone, B L Webber, et al.
Annals of Clinical Research|January 1, 1976
The hepatic lesion in protoporphyria (PP): preliminary studies of haem metabolism, liver structure and ultrastructureN R Pimstone, B L Webber, G H Blekkenhorst, et al.
British Journal of Anaesthesia|August 1, 1980
Screening of certain anaesthetic agents for their ability to elicit acute porphyric phases in susceptible patientsG H Blekkenhorst, G G Harrison, E S Cook, et al.
Pageof 13